Neha Yadav1, Arkaprava Majumdar1, and Vivek Tiwari1
1Department of Biological Sciences, Indian Institute of Science Education and Research Berhampur, Berhampur, India
Synopsis
Keywords: Alzheimer's Disease, Aging
The key to understanding brain-biomarkers depictive of normal cognition and cognitive impairment due to MCI (CI) and/or Alzheimer’s disease (CI-AD) is to identify the series of early, intermediate, and late events that encode brain health. The temporal and spatial order of events of brain health changes observed on MRI, associated with normal aging needs to be precisely delineated from the events associated with cognitive impairment. We have identified early, intermediate and late brain structural and microvascular events distinctive of CN, CI and CI-AD and developed an AI-based platform using an optimal number of MRI features distinctive of cognitive status.
INTRODUCTION
Aging is one of the major risks for dementia1. Changes in brain health with normal aging involve a cascade of brain structure, vascular, and microstructural changes over the period that may have similar or distinct kinetics, order, and magnitude than alterations associated with cognitive impairment. The temporal and spatial order of events of brain health changes observed on MRI, associated with normal aging, should be precisely delineated from the order and magnitude of events associated with cognitive impairment due to MCI (CI) and Alzheimer’s disease (CI-AD) as early, intermediate and late events. Advanced neuroimaging and dissection of cerebral small vessel pathologies using magnetic resonance imaging investigations will provide a precise measure of the rate of brain structure atrophy and hypertrophies combined with absolute volumetry and surface measures for delineating the early Brain Biomarkers associated with normal aging and the temporal and spatial changes leading to cognitive impairment (CI) because of MCI and/or Alzheimer’s Disease. Here we have employed a comprehensive segmentation of brain regions for structural and white matter hyperintensity quantification together with Artificial intelligence to establish quantitative and definitive early, intermediate and late biomarkers for identifying cognitive status as CN, CI, and CI-AD.METHODS
Brain segmentation was performed on 3D MPRAGE, T2-FLAIR, and Diffusion-weighted imaging (DWI) to determine neuroanatomic-volume and White matter hyperintensity (WMH) load from cognitively normal (CN, N=1106), cognitively impaired (CI, N=230) and cognitively-impaired subjects with an etiological diagnosis of AD (CI-AD, N=636) in the cohort of National Alzheimer’s Coordinating Center (NACC) with a total of 2642 MRI scans. Volumes of brain regions obtained from segmentation were normalized with total intracranial volume (ICV) using the following equation:
Vnorm = (Vestimated /VICV) x Vavg-ICV
Vnorm denotes normalized volume; Vestimated is the volume obtained from segmentation, and Vavg-ICV represents mean ICV. The rate of structural loss and ventricular hypertrophy across CN, CI and CI-AD subjects was determined using a linear regression-based model by setting up the age intercept at 50 years of age for all the 3 cognitive groups. The rate of progression of total WMH load with age across CN, CI, and CI-AD was obtained using an exponential fitting2. Moreover, the mean volumes and thickness were stratified3,4 into three age ranges, that is, 50-64 (early), 65-79 (intermediate), and >80 (late) to pinpoint the magnitude of alterations associated with CI and CI-AD patients compared to the cognitively normal subjects. Using the neuroanatomic volume and thickness, an optimal number of MRI features distinctive of cognitive status was optimized to develop an AI-based predictive platform.RESULTS and DISCUSSION
Linear regression of MRI determined gray matter (GM) and white matter (WM) volume with age revealed progressive loss wherein the rate of GM and WM loss was slower in CI-AD and CI groups compared to the CN (Fig.1 A,B,C,D). Mean volumetric analysis across the three age groups revealed a significant early decline in GM and WM in CI and CI-AD subjects compared to the CN while GM and WM loss were not distinctive between CI and CI-AD subjects across either of the age groups (Fig.1 E and F). Similarly, a significant reduction in hippocampal volume was distinctive of CI and CI-AD subjects from that of CN at all age groups but lacked sensitivity to distinguish CI and CI-AD subjects at early age groups (Fig.2). Progressive increase in ventricular volume is an early age indicator of CI and CI-AD groups (Fig. 2F). Investigation of medial temporal cortical thickness revealed that thinning of parahippocampal gyrus is an early feature distinctive between CI vs CI-AD (CI:1.91 ± 0.25 vs, CI-AD:1.72 ± 0.28, p <0.001) subjects in addition to clear distinctions from CN (1.98 ± 0.21 ) (Fig.3). Microvascular segmentation showed an exponential increase in deep and periventricular white matter hyperintensity (WMH) load with aging across all three cognitive cohorts. The increase in WMH rate was significantly faster for CI and CI-AD groups compared to CN (Fig.4). WMH load was a distinctive feature between CI and CI-AD subjects in the intermediate and late age groups. A machine learning model based on majority voting was developed using early intermediate and late neuroanatomical changes to predict cognitive status (Fig.5). A combination of 9-MRI features presents a highly precise and accurate prediction of cognitive status (~80%) using a simple random forest method.CONCLUSION
Parahippocampal gyrus thinning accompanied by ventricular increase marks the early feature distinctive of MCI and AD subjects while hippocampal reduction and WMH increase are the intermediate events distinctive of MCI and AD. A combination of 9 MRI-determined neuroanatomic features is predictive of distinct cognitive status. Neuroimaging investigations wrapped in AI provide high accuracy in determining cognitive status and may be used as an advanced tool for the clinical management of normal aging and pathological aging-associated brain health changes.Acknowledgements
MRI and Cognitive data were obtained from The NACC database funded by NIA/NIH Grant U24 AG072122.References
- Stephan Y, Sutin AR, Luchetti M, Terracciano A. Subjective age and risk of incident dementia: Evidence from the National Health and Aging Trends survey. J Psychiatr Res. 2018 May;100:1-4. doi: 10.1016/j.jpsychires.2018.02.008. Epub 2018 Feb 10. PMID: 29471080; PMCID: PMC5866231.
- Garnier-Crussard, A., Bougacha, S., Wirth, M. et al. White matter hyperintensities across the adult lifespan: relation to age, Aβ load, and cognition. Alz Res Therapy 12, 127 (2020). https://doi.org/10.1186/s13195-020-00669-4
- Vardarajan BN, Faber KM, Bird TD, Bennett DA, Rosenberg R, Boeve BF, Graff-Radford NR, Goate AM, Farlow M, Sweet RA, Lantigua R, Medrano MZ, Ottman R, Schaid DJ, Foroud TM, Mayeux R; NIA-LOAD/NCRAD Family Study Group. Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA). JAMA Neurol. 2014 Mar;71(3):315-23. doi: 10.1001/jamaneurol.2013.5570. PMID: 24425039; PMCID: PMC4000602.
- Geifman N, Cohen R, Rubin E. Redefining meaningful age groups in the context of disease. Age (Dordr). 2013 Dec;35(6):2357-66. doi: 10.1007/s11357-013-9510-6. Epub 2013 Jan 27. PMID: 23354682; PMCID: PMC3825015.